FMC stock pre-market at EUR 39.57: plus 0.03 percent
Published on 10/01/2026 at 07:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
FMC stock was at EUR 39.57 pre-market at 7:58 a.m. CEST on October 1, 2026, according to Lang & Schwarz. The price was up plus 0.03 percent versus the Lang & Schwarz prior close of EUR 39.56 on September 30, 2026.
Pre-market trading
Lang & Schwarz showed a bid of EUR 39.49 and an ask of EUR 39.65 at the quoted time. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of FMC stock.
China strategy announced
In a September 25, 2026 release, PR Newswire reported that Fresenius Medical Care is refining its China commercial strategy around a more localized portfolio, locally relevant innovation and a focused go-to-market approach. The company said China represents approximately 6 to 7 percent of Care Enablement operating-segment revenue.
Fresenius Medical Care said it plans to discontinue local production and sales of the 4008A hemodialysis system and exit its China peritoneal dialysis business while maintaining existing obligations. The company's investor newsroom said the measures are expected to result in approximately EUR 110 million in one-time costs, primarily related to impairment, scrappage and termination charges. The costs are expected to be recognized as a special item in the third quarter of 2026.
